One in vivo study suggested that a subpopulation of CRC, the CD133(+)CXCR4(+) colorectal cancer tumor-initiating cells (Co-TICs), presented a higher tumor formation capacity in a humanized orthotopic mouse model [69, 70]. The gene discussed is PROM1; the disease is colorectal carcinoma.